Baxalta Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
E Baxalta Cancels Partnership Deal With Onconova Therapeutics
Article By: Terry Chrisomalis
Friday, March 4, 2016 4:55 PM EST
Baxalta backs out of deal for rigosertib despite ongoing clinical trials, effective August 30.
In this article: BXLT, ONTX Also: SHPG
Read
Baxalta - Chart Of The Day
Article By: Jim Van Meerten
Monday, January 25, 2016 9:01 PM EST
Since the Trend Spotter signaled a buy on 1/14 the stock gained 2.22%.
In this article: BXLT
Read
Why Baxalta Is A Sell Now For Dividend Growth Investors
Article By: SureDividend
Monday, January 18, 2016 4:22 PM EST
Baxalta stock is trading for $40 per share. Baxalta investors who purchased at the closing price on July 6th, 2015 are sitting on 27% total returns (including dividends).
In this article: BXLT
Read
View From The Hill (Jan-6-2016): Go And Expect More Pain Before Gain
Article By: Hillbent
Wednesday, January 6, 2016 11:08 AM EST
As stated yesterday, the market internals are weak and therefore the resumed acceleration in bearish momentum was more or less expected. Today’s violation of key support levels was not a surprise either.
In this article: AMP, AN, BBY, CF, CMG, DLPH, ESV, FLS, GM, HES, IPG, PHM, RIG, SLB, SLG, SWN, URI, UTX, WMB, AVGO, BBBY, AAL, WBA, QRVO, BXLT
Read
Charles Schwab: On The Market - January 4, 2016
Article By: Marvin R Clark
Tuesday, January 5, 2016 1:42 AM EST
The U.S. stock markets rang in the New Year with solid losses, with another series of disappointing Chinese manufacturing data and escalating tensions in the Middle East as a backdrop to resurfacing global concerns.
In this article: ACHC, SHPG, BXLT
Read

PARTNER HEADLINES

Latest Tweets for $BXLT

No tweets yet!